PHARMCHINA, China’s leading exhibition for Finished Dosage Forms (FDFs) and ready-to-use medicines, returns for its landmark 90th edition this spring. Taking place at the Guangzhou China Import and Export Fair Complex on May 21–23, 2025, the event brings together pharmaceutical professionals, innovators, and decision-makers from across China and all over the world to connect, collaborate, and drive industry growth.

As one of the most influential events in China’s pharmaceutical sector, PHARMCHINA offers direct access to the full value chain. It creates opportunities for suppliers and buyers to meet, for businesses to explore new markets, and for stakeholders to stay ahead of policy and market developments. For companies looking to enter or expand within China’s rapidly growing healthcare economy, PHARMCHINA remains an essential gateway.

A Strategic Platform for the Pharma Ecosystem
Organized by Reed Sinopharm Exhibitions, PHARMCHINA Spring 2025 is designed to connect reliable Chinese and international manufacturers and suppliers with key commercial players like agents/distributors, import-export traders, e-commerce platforms, and major drugstore chains. The event plays a vital role in facilitating supply chain integration and supporting the commercialization of new pharmaceutical products. Moreover, it serves as a key venue for sharing insights on China's critical policies, market access pathways, channel dynamics, and future trends.

Part of a Powerhouse Industry Cluster
PHARMCHINA runs concurrently and is co-located with API China—China’s premier show covering all materials required for the production of medicines and health products—and NHNE (Natural Health & Nutrition Expo), an exhibition for health, nutrition, and dietary supplements. This tri-show format offers unparalleled access across the pharmaceutical and health value chain—making it an all-in-one efficient visit. Together, the three co-located shows offer attendees a comprehensive view of the entire pharmaceutical and health ecosystem, enabling efficient sourcing and seamless cross-sector collaboration.

What to Expect at the 2025 Spring Edition
PHARMCHINA expects over 2,000 exhibitors, including 70% of China’s Top 100 pharmaceutical manufacturers, alongside a strong lineup of international participants.

Confirmed exhibitors include:
- Sinopharm Group
- General Technology China Pharmaceutical
- Guangzhou Pharmaceutical Group
- Renfu Pharmaceutical
- Huahai Pharmaceutical
- Xinhua Pharmaceutical
- Lukang Pharmaceutical
- Hongri Pharmaceutical
- Xianjun Pharmaceutical
- Yuekang Pharmaceutical Group
- Chuangnuo Pharmaceutical
- Propharma

Attendees gain access to a broad range of products and innovations, including:
- Chemical drugs and Chinese patent medicines
- OTC and primary channel medicines
- Traditional Chinese medicine and herbal products
- Biological products and new drug innovations
- Medical devices and consumables
- R&D support, pharmaceutical packaging, and logistics
- Digital tools for pharma marketing and operations


Insight-Packed Forums with PHARMACONGRESS
PHARMCHINA also hosts PHARMACONGRESS, a high-level conference series featuring over 30 sessions led by industry executives, policy experts, and academic leaders.
The program addresses seven core areas:
- New Quality Productivity
- Commercialization
- Outpatient
- Traditional Chinese Medicine
- International
- Biomedicine
- Academic Forums

Sessions highlight advancements in drug development, explore new market opportunities, and address industry challenges. Speakers offer strategic guidance on navigating China’s regulatory landscape and unlocking commercial value.

Why Professionals Should Attend PHARMCHINA
PHARMCHINA offers a unique blend of sourcing, strategy, and relationship-building—making it a must-attend for companies or professionals with interests in China’s pharmaceutical sector.
- Access the Chinese FDF Market – Engage with top domestic and international pharma players.
- Build Strategic Partnerships – Use matchmaking tools to explore sourcing, distribution, and joint venture (JVs) opportunities.
- Gain Critical Market Insights – Attend 50+ expert-led seminars on policy trends and industry developments.
- Leverage Trusted Expertise – Rely on the credibility of PHARMCHINA’s 40-year legacy and Reed Sinopharm’s proven track record.
- Plan Smarter with Digital Tools – Use the Larspring platform to browse exhibitors and schedule meetings in advance.
- Enjoy Seamless International Support – Access visa services and tailored assistance to ensure a productive visit.

Where Pharma’s Future Takes Shape
PHARMCHINA Spring 2025 is more than just a trade show—it is where ideas become reality, partnerships are formed, and the future of pharma is shaped. Whether sourcing new products, exploring licensing deals, or navigating market entry, industry professionals find unmatched value at this must-attend event.

For more information, visit https://www.pharmchina.com.cn/en/
Visitor registration is now open. https://reg.reed-sinopharm.com/pc/#/login?id=5ea87ed214a04df7b94f108a33bcf391&channelUuid=0ee62be9d87149eaa9aaf89c9b7cbad0

Register today and be part of China’s premier pharmaceutical event.